NCT03399799 2026-03-12MonumenTAL-1Janssen Research & Development, LLCPhase 1 Active not recruiting279 enrolled 1 FDA
NCT02074839 2025-06-08Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationServierPhase 1 Recruiting291 enrolled 3 FDA